In the United States of America, microscopic hematuria has a prevalence of somewhere between 2% and 31%. Higher rates exist in individuals older than 60 years of age and those with a current or past history of smoking. Only a fraction of individuals with microhematuria are diagnosed with a urologic<unk> . When asymptomatic populations are screened with dipstick and/or microscopy medical testing about 2% to 3% of those with hematuria have a urologic malignancy. Routine screening is not recommended. Individuals with risk factors who undergo repeated testing have higher rates of urologic malignancies. These risks factors include age (>35 years), male gender, previous or current smoking, chemical exposure (e.g., benzenes or aromatic amines), and prior pelvic radiation therapy. Children In pediatric populations, the prevalence is 0.5–2%. Risks factor include older age and female gender. About 5% of individuals with microscopic hematuria receive a<unk>  diagnosis. 40% of individuals with macroscopic hematuria (blood easily visible in the urine) receive a<unk>  diagnosis.
symptom of Urethral cancer
symptom of Bladder cancer
symptom of Prostate cancer
symptoms of Bladder cancer
symptom of Benign prostatic hyperplasia
symptom of Testicular cancer
symptom of Pelvic inflammatory disease
medical cause of Dysmenorrhea